The New Era in Alzheimer’s Disease: Integrating Diagnostic Biomarkers and ATTs

Diagnosing Alzheimer’s Disease in the Biomarker Era: Promises and Pitfalls | Professor Ron PetersenПодробнее

New Era for Alzheimer’s Disease?Подробнее

Advances in Biomarkers and Treatment of Alzheimer's DiseaseПодробнее

The future of diagnostics in the evolving Alzheimer’s disease care landscapeПодробнее

Biomarker Changes Preceding Alzheimer’s Disease | NEJMПодробнее

Decoding #Alzheimer's Disease : The Truth Behind Blood #BiomarkersПодробнее

Alzheimer’s Disease 2024: The Role of BiomarkersПодробнее

The New Era of ATTs in Alzheimer's Disease: Key Evidence, Considerations, and Best PracticesПодробнее

Journey to a New Era for Alzheimer's Disease - Introduction to the ProgramПодробнее

Moving into the Digital Era of Alzheimer’s Disease ResearchПодробнее

New Blood Test for Alzheimer’s DiseaseПодробнее

Blood-based biomarkers: Supporting the diagnosis and treatment of Alzheimer’s diseaseПодробнее

Redefining Alzheimer's Disease: New Diagnostic CriteriaПодробнее

Access to Alzheimer’s disease diagnostic biomarkers in clinical routineПодробнее

Beyond Aβ and p-Tau: novel biomarkers under investigation for Alzheimer’s diseaseПодробнее

Complete CSF biomarker profile for Alzheimer’s disease in the era of automation and standardizationПодробнее

Current understanding of Alzheimer’s disease diagnosis and treatment [version 1; refe... | RTCL.TVПодробнее

Plenary 2: From Biomarkers to Precision Medicine in Alzheimer's DiseaseПодробнее

Uncovering the Reality of End-Stage Alzheimer's: How the Dying Process Unfolds 😶‍🌫Подробнее